New7

New7

New7 related products

Structure Cat No. Product Name CAS No. Product Description
V4573 (4E)-SUN9221 222318-55-0 (4E)-SUN9221 is a potent α1-adrenergic receptor and 5-HT2 receptor blocker (antagonist) with anti-hypertensive (blood pressure lowering) and antiplatelet aggregation effects.
V4720 (±)-BI-D 1416258-16-6 (±)-BI-D is a novel and potent allosteric/noncatalytic site integrase inhibitor that binds integrase at the LEDGF/p75 binding site.
V4605 5Z-7-Oxozeaenol 253863-19-3 5Z-7-Oxozeaenol, a natural anti-protozoan compound isolated from fungae, is a novel, potent irreversible / covalent and selective inhibitor ofTAK1andVEGF-R2withIC50s of 8 nM and 52 nM, respectively.
V4657 A-437203 220519-06-2 A-437203 is a novel, potent and selectiveD3receptor antagonist withKiof 71, 1.6, and 6220 nM for D2, D3, and D4receptors, respectively.
V4566 ABBV-4083 1809266-03-2 ABBV-4083, a Tylosin A analog withimprovements in anti-Wolbachiaand anti-filarial activity and oral pharmacokinetic properties, is a novel macrofilaricidal agent which acts by targeting the worm-symbiont Wolbachia bacterium.
V4690 ACY-1083 1708113-43-2 ACY-1083 is a novel, potent, selective and brain-penetrant HDAC6 inhibitor with an IC50 of 3 nM.
V4689 ACY-957 1609389-52-7 ACY-957 is a novel, potent and selective inhibitor ofHDAC1andHDAC2isoforms withIC50s of 7 nM, 18 nM, and 1300 nM against HDAC1/2/3, respectively.
V4985 Ajulemic acid 137945-48-3 Ajulemic acid (also known as lenabasum) is a cannabinoid CB2 receptor agonist with the potential for treatment of skin-predominant dermatomyositis.
V4738 AMG2850 1470018-52-0 AMG2850 is a novel, potent, orally bioavailable and selectivesmall molecule antagonist oftransient receptor potential melastatin 8 (TRPM8).
V5074 Amrubicin HCl (Calsed) 92395-36-3 Amrubicin HCl (also known as SM-5887 hydrochloride), a third-generation synthetic 9-amino-anthracycline, is a potent DNAtopoisomerase IIinhibitor with antineoplastic activity.
V4846 AMY-101 acetate 1427001-89-5 AMY-101 (also known as Cp40) is a peptidic inhibitor of the central complement component C3.
V5051 ANT431 1639972-90-9 ANT431 is a novel and potent inhibitor of metallo-β-lactamase with the potential for the treatment of carbapenem-resistant enterobacteriaceae infections.
V5028 Arfolitixorin 31690-11-6 Arfolitixorin, an intravenously administered folate-based compound,is a novel and potent antifolate modulator that isbeing developed by Isofol Medical AB, for the treatment of cancer.
V4565 ARN 077 1373625-34-3 ARN 077 (ARN-077) is a novel, potent and selectiveN-acylethanolamine acid amidase (NAAA)inhibitor with anIC50of 7 nM for human NAAA.
V4903 Arzoxifene HCl 182133-27-3 Arzoxifene (also known as LY353381) is a novel, potent, synthetic aromatic derivative, and selectiveestrogen receptorantagonist in mammary and uterine tissue while acting as an estrogen agonist to maintain bone density and lower serum cholesterol.
V5005 Atrial Natriuretic Peptide (ANP) (1-28) 89213-87-6 Carperitide [SUN4936; SUN-4936;Atrial Natriuretic Peptide (ANP) (1-28), novel human, porcine] is an endogenous 28-amino acid hormone produced/ecreted by the human heart in response to cardiac injury and mechanical stretch.
V4991 AZD3147 1101810-02-9 AZD3147 (AZD-3147) is an highly potent and selective dual inhibitor of mTORC1/2 with IC50 of 1.5 nM.
V4982 AZD3458 (PI3Kγ inhibitor 3) 2132961-46-5 AZD-3458 (PI3Kγ inhibitor 3) is a novel, potent, orally bioavailable and highly isoform selectivePI3Kγinhibitor with anticancer activity.
V4732 Balamapimod 863029-99-6 Balamapimod (formerly also known as MKI-833) is a novel, potent, and reversible Ras/Raf/MEK inhibitor.
V4601 Bamirastine 215529-47-8 Bamirastine (also known as TAK-427),a new imidazopyridazine derivative, is a novelantihistamine compound withantiallergic effects.
Contact Us Back to top